Surgical Site Infections (SSIs) continue to be one of the most common and costly healthcare-associated infections – with potentially catastrophic consequences to patients. Despite significant advances in the area of wound closure and healing, SSIs still occur in up to five percent of patients undergoing surgery1-3 and the results can be life altering.
In the United States alone, there are more than 300,000 cases of SSIs occurring each year3. Those who are impacted by SSIs increase their length of hospital stay by up to 11 days1, 3, are five times more likely to be readmitted to the hospital1 and two times more likely to spend time in an intensive care unit1. A single SSI can cost up to $39,0004, costing the healthcare system an additional $3.5 to $10 billion annually1-3. These numbers are staggering.
The sad reality is that we see the catastrophic impacts of SSIs far too often.
In 2006, Alicia Cole went in for a routine fibroid surgery only to later become infected with flesh-eating disease, requiring seven additional surgeries, nine blood transfusions and a two-month hospital stay. U.S. Marine, James Bane, underwent a discectomy after his disc ruptured, crushing his sacral nerve. Five days later, the surgical site became infected, putting him into septic shock. After his two-week hospital stay recovering from the infection, it left him in more pain than before his surgery. The impact of SSIs that these two patients have faced is life changing.
SSIs are challenging for physicians to address since they can happen from varying types of surgeries at the hands of the most skilled surgeons. The good news is – SSIs are preventable and there are proactive measures that healthcare professionals can take to reduce the risk of these infections. However, it is up to each and every medical professional to mitigate these risks. Here are some proactive measures OR staff can take to provide extra risk reduction…
Another way to mitigate risks is to use Ethicon’s Plus Antibacterial Sutures, the first and only triclosan-coated sutures available worldwide. According to a meta-analysis of 21 randomized controlled trials, it demonstrated that using triclosan-coated sutures can help reduce the risk of an SSI by an average of 28 percent5*+. Triclosan-coated sutures are now recognized and recommended by national and international health organizations and professional societies as reducing bacterial colonization of the suture, a known SSI risk factor7-9.
Using antibacterial sutures is a simple choice that gives physicians the power to reduce a persistent risk from the surgical equation. They add an extra layer of protection for patients, and it’s simple to implement into surgical procedures. Triclosan-coated sutures should be an indispensable component of every operating theater’s infection prevention protocol to ensure medical professionals are using technology to address as many known SSI risk factors as possible.
In addition to using an antibacterial suture, there is another wound closure option that avoids the risk factor of suture colonization by bacteria– and that is skin closure without sutures, a mesh reinforced topical skin adhesive, which closes the surgical incision at every point along its length.
The bottom line is—SSIs are a global healthcare concern that needs to be addressed more widely. One surgical site infection is one too many. As we forge ahead, together, antibacterial sutures and additional proactive infection prevention protocols can one day take us to a world where SSIs are a thing of the past. Learn more about these proactive surgical site infection prevention protocols and join the Zero Starts with One movement.
*In a meta-analysis of 21 RCTs, 6462 patients, 95% CI: (14, 40%), P<0.001
†All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL® Plus, VICRYL® Plus, and PDS® Plus)
© Ethicon Inc. 2021